Fda Approves First Covid Treatment For Young Kids
Remdesivir has been a successful treatment option for adults and children over the age of 12 since its initial emergency use authorization (EUA) in October 2020. Now, the treatment’s use for children has been granted full FDA approval. It’s available for children and infants over 28 days old and weighing at least 7 pounds who test positive for COVID-19, and are hospitalized or at high risk for severe illness....